HRME: Screening for Cervical Cancer and Its Precursors in Low-Resource Settings

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

December 31, 2016

Conditions
Neoplasia of the Uterine CervixCancer PreventionCervical Intraepithelial Neoplasia
Interventions
DEVICE

High-Resolution Microendoscopy Imaging

Innovative technique to evaluate epithelial cell morphology in situ. The device is not invasive and does not exchange energy with human body.

All Listed Sponsors
collaborator

William Marsh Rice University

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

Barretos Cancer Hospital

OTHER

NCT02494310 - HRME: Screening for Cervical Cancer and Its Precursors in Low-Resource Settings | Biotech Hunter | Biotech Hunter